FDA Import Refusal 799-9115010-2/21/1 — Glaxosmithkline
The FDA refused shipment 799-9115010-2/21/1 from Glaxosmithkline (United Kingdom) on Jun 13, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 13, 2022
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 66VCA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75